(Q31083753)

28 June 2017

1 reference

title

Carbamazepine versus phenytoin monotherapy for epilepsy (English)

1 reference

28 June 2017

0 references

1 reference

C Tudur Smith

1

1 reference

28 June 2017

A G Marson

series ordinal

2

1 reference

28 June 2017

H E Clough

series ordinal

3

1 reference

28 June 2017

P R Williamson

series ordinal

4

1 reference

28 June 2017

publication date

1 January 2002

1 reference

Cochrane Database of Systematic Reviews

28 June 2017

published in

1 reference

28 June 2017

issue

2

1 reference

28 June 2017

page(s)

CD001911

1 reference

A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001911

Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001911

Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001911

Carbamazepine and phenytoin in epilepsies refractory to barbiturates: efficacy, toxicity and mental function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001911

Psychotropic effects of carbamazepine in epilepsy: A double-blind comparison with phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001911

Carbamazepine vs phenytoin. A controlled clinical trial in focal motor and generalized epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001911

Comparative cognitive effects of anticonvulsants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001911

Comparing the cognitive effects of phenytoin and carbamazepine in long-term monotherapy: a two-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001911

Results of a nationwide Veterans Administration Cooperative Study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001911

Carbamazepine--A double-blind comparison with phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001911

Carbamazepine and the Electroencephalogram of Epileptics: A Double Blind Study in Comparison to Phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001911

A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001911

Course of pregnancy and fetal outcome following maternal exposure to carbamazepine and phenytoin: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001911

Trials to assess equivalence: the importance of rigorous methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001911

Absence seizures and carbamazepine in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001911

Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001911

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001911

A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001911

Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001911

Carbamazepine for epilepsy. A controlled prospective evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001911

Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001911

A double-blind study comparing carbamazepine with phenytoin as initial seizure therapy in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001911

A comparative controlled study between carbamazepine and diphenylhydantoin in psychomotor epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001911

Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001911

Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001911

10.1002/14651858.CD001911

21 January 2018

Identifiers

DOI

1 reference

28 June 2017

1 reference